Ramasamy K, Bahlis NJ, Kumar SK, Kumar A, Cranmer H, Wang B, Dabora J, Labotka R, Richardson PG, Moreau P. Adjusting for subsequent therapies in the TOURMALINEMM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone. haematol [Internet]. 2020Sep.10 [cited 2024Jul.27];. Available from: https://haematologica.org/article/view/haematol.2023.283713